The Asia Pacific Optical Imaging Market would witness market growth of 14.1% CAGR during the forecast period (2022-2028).
Exogenous fluorescence probes come in a variety of forms, including small molecules, peptide- and affibody-based (Affibody AB), as well as substrate- and activity-based ones. The development of probes in the near-infrared (NIR) window, maximum quantum yield efficiency, huge stoke shifts, and bleaching resistance have all recently made strides. Moreover, fluorescent proteins have been extensively genetically encoded and modified in a wide variety of applications, from neurology to cancer imaging, since the discovery of green fluorescent proteins (GFP) from aequorin.
For the majority of malignancies, radical excision during surgery is the chosen course of action. Thus, realistic techniques for improving tumor resection and techniques for seeing the surrounding nerves or tissue and avoiding damaging them are sought. The success of the surgery depends on knowing the tumor and its important structures. It is crucial to use imaging camera prototypes together with the appropriate fluorescent dye. Examples include fluorescence cystoscopy, intraoperative image-guided transoral robotic surgery, and multispectral normalized fluorescence imaging systems, all at the clinical testing stage for open-air intraoperative testing for melanoma, bladder, ovarian, breast, and cervical malignancies.
The average life expectancy in Japan has been rising, and it is now one of the countries with the longest life expectancies. The average life expectancy was 87.32 years for women and 81.25 years for males as of 2018. By 2065, the average life expectancy for men and women is anticipated to be 84.95 and 91.35 years, respectively. The proportion of individuals over 65 (the old) has also been rising and is now one of the highest in the world. In 2019, it was 28.4%; by 2036, it should be 33.3%; and by 2065, it should be 38.4%. These elements would support the growth of the regional market.
The China market dominated the Asia Pacific Optical Imaging Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $262.1 Million by 2028. The Japan market is experiencing a CAGR of 13.4% during (2022 - 2028). Additionally, The India market would exhibit a CAGR of 14.8% during (2022 - 2028).
Based on Product, the market is segmented into Imaging Systems, Illuminating Systems, Camera, Software and Lenses & Others. Based on End User, the market is segmented into Hospitals & Clinics, Research Laboratories and Pharmaceutical & Biotechnology Companies. Based on Technique, the market is segmented into Optical Coherence Tomography, Near Infrared Spectroscopy, Hyperspectral Imaging and Photoacoustic Tomography. Based on Application, the market is segmented into Pathological Imaging and Intraoperative Imaging. Based on Therapeutic Area, the market is segmented into Oncology, Ophthalmology, Cardiology, Dermatology, Neurology and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Optical Imaging Market is Projected to reach USD 3.1 Billion by 2028, at a CAGR of 13.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Carl Zeiss AG, Leica Microsystems GmbH (Danaher Corporation), Abbott Laboratories, Canon, Inc. (Canon Medical Systems Corporation), PerkinElmer, Inc., Topcon Corporation, Hamamatsu Photonics K.K., Koninklijke Philips N.V., Heidelberg Engineering, Inc. and Visionix Ltd.
By Product
By End User
By Technique
By Application
By Therapeutic Area
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 